This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

£1million month-end hit will cripple Community Pharmacy

CPNI issued a press release on 30th April 2025 detailing the financial impact of the new minimum wage and national insurance changes (NIC) in the first month alone.  The statement is available here and across CPNI social media channels: FacebookX and LinkedIn.

Contractors are invited to share these posts on their social media channels.

Independent Pharmacy Awards 2025

Nominations are open for The Independent Pharmacy Awards which will take place on Thursday 2nd October 2025, at the House of Commons.  The awards are an opportunity to highlight and celebrate the brilliance and endurance of community pharmacy teams across the UK. 

There are six categories including Pharmacy Team of the Year, an award previously won by McCartans Pharmacy in Newry.

Further information is available here.

RPS Survey

The Royal Pharmaceutical Society (RPS) sets the curriculum for Post-Registration Foundation Pharmacist development programmes such as the NICPLD Post-Registration Foundation course.

As a result of reforms to the GPhC/PSNI Initial Education and Training Standards, all newly qualifying pharmacists from 2026 onwards will be annotated prescribers at the point of registration.  RPS is therefore planning to revise the Post-Registration Foundation curriculum to align with the evolving roles undertaken by pharmacists in all sectors.  When finalised, the new curriculum will be referred to as the Enhanced Curriculum.

To inform development of the new curriculum, RPS is conducting a survey and would particularly welcome the views of community pharmacists.  The survey will remain open until Friday 16th May 2025.

FAO Community Pharmacies in the Belfast Area: Falls Prevention Roadshow

Community pharmacy teams may wish to share this FLYER relating to an upcoming roadshow on falls prevention with relevant patients.

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor
NICPLD issued correspondence today which advises that the opt-in window for involvement in FTY 2026/2027 has been extended to 5pm on 9 May 2025.  Earlier correspondence had indicated that the window would close on 25 April 2025.

SUMMARY

  • If a pharmacy chooses to opt-in they will receive a link asking them to complete a second step where they upload their training placement details and accept the Terms of Participation
  • The closing date for the second step is 16 May 2025.

IMPORTANT CONTRACTOR CONSIDERATIONS

  • We would ask contractors who “opt-in” to be aware that should they then complete the second step and accept the Terms, they are considered to have given their commitment to providing the relevant placement(s) to any trainee allocated to them by the NICPLD selection process.
  • Contractors must be aware that some important aspects of the FTY 2026/2027 programme have not been finalised by NICPLD and are not likely to be available until 2026, such as the 2026/2027 Framework, Curriculum, Salary, Training Grant and programme SOPs.
  • CPNI contractor meetings will take place on 14 May (Belfast) and 15 May (Cookstown), at which arrangements relating to the 2026/2027 FTY process will be discussed.

ACTION

Contractors considering participation in the FTY 2026/2027 programme should ensure that they take the following steps prior to opting-in, uploading placement details, or accepting the Terms of Participation:

Should you have any questions, please do not hesitate to contact the CPNI team or email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The final update of concessionary prices were granted yesterday for April 2025:
DrugPack SizeConcessionary Price
Ascorbic acid 100mg tablets28£30.49
Buprenorphine 2mg sublingual tablets sugar free7£2.73
Carbocisteine 375mg capsules120£3.01
Clarithromycin 250mg/5ml oral suspension70£9.93
Desmopressin 120microgram sublingual tablets sugar free30£16.77
Diclofenac sodium 50mg gastro-resistant tablets28£0.88
Dutasteride 500microgram capsules30£2.54
Estradiol 10microgram pessaries24£11.49
Febuxostat 80mg tablets28£2.88
Imipramine 10mg tablets28£2.00
Imipramine 25mg tablets28£2.18
Levofloxacin 500mg tablets5£3.99
Levofloxacin 500mg tablets10£7.98
Mefenamic acid 500mg tablets28£5.78
Mometasone 0.1% ointment100£11.82
Mometasone 50micrograms/dose nasal spray140£8.64
Nortriptyline 10mg tablets100£4.18
Nortriptyline 25mg tablets100£2.67
Paracetamol 500mg soluble tablets100£20.94
Paracetamol 500mg soluble tablets24£5.02
Pioglitazone 15mg tablets28£2.23
Pioglitazone 30mg tablets28£1.38
Pioglitazone 45mg tablets28£29.97
Pivmecillinam 200mg tablets10£6.51
Pramipexole 88microgram tablets30£3.50
Propantheline bromide 15mg tablets112£98.16
Prucalopride 1mg tablets28£16.92
Trihexyphenidyl 5mg tablets84£14.40
Trimethoprim 200mg tablets6£1.79
Trimethoprim 200mg tablets14£4.19
Vardenafil 10mg tablets4£11.49
Venlafaxine 37.5mg modified-release tablets30£9.90

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
For the Attention of Community Pharmacies Currently Providing the Opioid Substitution Treatment (OST) Service
Dear Colleague
SPPG issued correspondence on 10 April 2025 regarding the community pharmacy OST service.  Note: The link for return of OST contracts will now remain open until 9 May 2025.

SUMMARY

  • A new contract for the community pharmacy OST service is being implemented from April 2025.
  • The contract will further enhance governance arrangements for the delivery of the OST service and ensure timely payment of the retainer fee.
  • Pharmacies that currently dispense OST prescriptions are asked to submit a new contract using the MS forms link.
  • Note: The link for return of OST contracts will now remain open until 9 May 2025.
  • Service documentation including the new service specification and relevant resources are available on the BSO website here.
  • Pharmacy staff involved in the provision of the OST service are asked to ensure they are familiar with the necessary resources in line with the service specification and contract.
  • The NICPLD live webinar ‘Opioid Substitution Therapy‘ is scheduled for 21 May 2025, and will be recorded for those unable to attend.

ACTION

Contractors are asked to:

  • Review the correspondence issued by SPPG on 10 April 2025 and share with all relevant team members.
  • Complete a new contract for the OST service by 9 May 2025.
    • Please note: Those pharmacies who have already completed a new OST service contract recently do not need to resubmit.

Please contact Michael McCabe (michael.mccabe@hscni.net), Pharmacy Adviser if you have any further queries.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
*** Survey Closes Today 30 April 2025 ***
Dear Contractor
Further to the CPNI update on Experiential Learning (EL) which issued on 14 March 2025, contractors are reminded that there is still time to complete the CPNI EL survey.  The survey has been extended and will now close on 30 April 2025.

SUMMARY

  • The CPNI EL survey provides contractors with an opportunity to give their views on what is working well with EL in community pharmacy, and what improvements may be helpful.
  • NICPLD has indicated that EL feedback will be used to inform a review of the programme and the development of an ongoing EL strategy.

ACTION

Contractors are advised to:

EL queries can be sent to the NICPLD programme lead Helen Hirst by emailing h.hirst@qub.ac.uk.  Alternatively, should you wish to speak to a member of the CPNI team please feel free to email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for April 2025:
DrugPack SizeConcessionary Price
Alfuzosin 2.5mg tablets60£4.30
Amiodarone 200mg tablets28£1.99
Buprenorphine 8mg sublingual tablets sugar free7£9.25
Carbimazole 20mg tablets100£2.65
Carbimazole 5mg tablets100£4.63
Codeine 15mg/5ml linctus200£15.68
Codeine 15mg/5ml linctus sugar free200£12.58
Cyclizine 50mg/1ml solution for injection ampoules5£4.07
Desogestrel 75microgram tablets84£2.40
Erythromycin 250mg gastro-resistant tablets28£5.49
Esomeprazole 20mg gastro-resistant capsules28£1.81
Exemestane 25mg tablets30£17.57
Gabapentin 600mg tablets100£25.13
Isosorbide mononitrate 10mg tablets56£2.54
Lactulose 3.1-3.7g/5ml oral solution500£5.43
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops2.5£4.09
Latanoprost 50micrograms/ml eye drops2.5£1.82
Lercanidipine 10mg tablets28£2.61
Lercanidipine 20mg tablets28£3.52 
Letrozole 2.5mg tablets28£4.42
Memantine 10mg tablets28£2.19
Memantine 10mg/ml oral solution sugar free50£16.24
Memantine 20mg tablets28£3.06
Methocarbamol 750mg tablets100£7.54
Methylphenidate 10mg tablets30£3.80
Methylphenidate 5mg tablets30£7.36
Metronidazole 200mg tablets21£1.31
Metronidazole 400mg tablets21£2.02
Morphine sulfate 10mg/1ml solution for injection ampoules10£4.37
Oxybutynin 2.5mg tablets56£1.12 (previously £1.11)
Oxycodone 5mg/5ml oral solution sugar free250£9.22
Paracetamol 500mg effervescent tablets100£6.56
Pregabalin 20mg/ml oral solution sugar free473£40.06
Prochlorperazine 3mg buccal tablets50£19.00
Tadalafil 10mg tablets4£0.93
Tadalafil 5mg tablets28£4.96
Telmisartan 40mg tablets28£5.09
Trihexyphenidyl 2mg tablets84£14.85
Trimethoprim 100mg tablets28£1.06
Trospium chloride 20mg tablets60£16.15
Vardenafil 20mg tablets4£19.69
Venlafaxine 225mg modified-release capsules28£28.54
Water for injections 10ml ampoules10£2.79

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive